课题基金 / 基金详情

Experimental Studies on the Occurrence of Cardiac Hypertrophy in Ischemic Heart and Its Possible Mechanisms

Experimental Studies on the Occurrence of Cardiac Hypertrophy in Ischemic Heart and Its Possible Mechanisms
缺血性心脏心肌肥厚发生及其可能机制的实验研究
批准号:
63480224
负责人:
SASAYAMA Shigetake
金额:
$4.16万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1990

项目摘要

项目成果

SASAYAMA Shigetake的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We evaluated whether repeated brief coronary occlusion induces myocardial hypertrophy in the region subjected to reversible ischemic insult. In 5 conscious dogs, a subendocardial segment length in the area perfused by the left circumflex coronary artery (LCCA) was measured along with left ventricular pressure. After complete recovery from surgery, 167 (mean) 2 min LCCA occlusions were repeated for 22 days. The resting end-diastolic segment length in the LCCA area was increased by 6.6% (p<0.05). On histologic examination, there was a disproportionate increase in myocardial cell size in the LCCA area compared with the area perfused by the left anterior descending coronary artery (LAD) (18.2 mu vs. 15.4 mu, p<0.05). In an additional similarly instrumented 5 dogs, myocardial cell size in the LCCA and LAD areas was comparable (14.2mu vs. 14.0mu, p=NS). We conclude that the repeated brief ischemic episodes induced regional myocardial hypertrophy confined to the ischemic area.The maximal bind … More ing site density (Bmax) for [^3] prazosin binding was 13.0<plus-minus>6.5 (fmol/mg protein) (mean <plus-minus>SD) in the nonischemic area and 14.6<plus-minus>9.5 (fmol/mg protein) in the ischemic area. The dissociation constant (K_D) was 0.17<plus-minus>0.13 (nM) in the nonischemic area and 0.17<plus-minus>0.17 (nM) in the ischemic area. Both the parameters were not significantly different. The Bmax, 72.2<plus-minus>35.5 (fmol/mg protein) and the K_<D'> 1.00<plus-minus>0.25 (nM) for H dihydroalloprenolol binding, in the nonischemic area were not significantly different from those (Bmax : 76.8<plus-minus>25.8 (fmol/mg protein), K_<D:> 1.43<plus-minus>0.75 (nM) in the ischemic area, respectively. The Bmax, 250<plus-minus>126 (fmol/mg protein) and the K_<D'> 0.24<plus-minus>0.03 (nM) for [^3H] (+) PN200-100 binding in the nonischemic area were also insignificantly different from 175<plus-minus>19 (fmol/mg protein) and 0.03<plus-minus>0.14 (nM) in the ischemic area, respectively. These results suggest that the mechanism contributing to myocardial hypertrophy induced by repeated occlusion appears to involve no quantitative and qualitative changes of adrenergic alpha1 and beta, and also calcium channel drug binding receptors. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Analysis of the role of p38 MAP kinase in heart failure using transgenic mice
    • 批准号:
      11307012
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $24.0万
    • 财政年份:
      1999
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    Analysis of novel proteins produced by vascular tissues and their clinical application
    • 批准号:
      11557052
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.19万
    • 财政年份:
      1999
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    Analysis of signal transduction among cells in the pathogenesis of heart failure and its application for the diagnosis and treatment
    • 批准号:
      08407018
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $24.96万
    • 财政年份:
      1996
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    DEVELOPMENT OF GENE THERAPY FOR CARDIOVASCULAR DISEASES
    • 批准号:
      08044273
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $10.11万
    • 财政年份:
      1996
    • 负责人:
      SASAYAMA Shigetake
    • 依托单位:
    海外基金